INTRODUCTION:

Nanotechnology is an arising field taking all things together of science, designing and innovation. It is a novel interdisciplinary territory of thorough exploration that joins medication and other life sciences. It offers a potential for remarkable and novel methodologies with expansive range of utilization in disease treatment including zones like diagnostics, therapeutics and forecast. The principle favorable position of particles in the nano-metric reach is its improved physical and synthetic properties. The significant boundaries in medication conveyance incorporate molecule size, hydrophobicity, crystallinity and surface charge. Over 40% of new substance elements being created through drug revelation programs are ineffectively water soluble. The detailing of ineffectively water-soluble medications has consistently been a difficult issue looked by drug researchers.

There are numerous customary strategies like micronization, solubilisation utilizing co-solvents, surfactant scatterings and precipitation procedure has been created for improving dissolvability of inadequately water dissolvable drugs. Yet, these procedures show impediments to the medications which are not dissolvable in both fluid and organic solvents. Nanosuspension innovation can be utilized to take care of the issues related with different methodologies depicted before. Nanosuspension is colloidal scattering of nano-sized medication particles balanced out by surfactants. They can likewise characterize as a biphasic framework comprising of unadulterated drug particles scattered in a liquid vehicle. The width of suspended molecule is under 1µm in size.^1,2,3

Need of Nanosuspension for Solubility Enhancement:

Pharmacokinetic investigations of BCS class-II drugs showed that they have a low oral bioavailability, which might be because of helpless water solvency of drug. There are numerous classical drug approaches to improve drug dissolution rate like dissolution in liquid combinations with the organic solvents, development of ß-cyclodextrin buildings, strong scatterings and drug salt structure. During most recent 20 years another innovation, lessening drug molecule size, has been created to expand drug dissolution rate. As indicated by Noyes-Whitney condition, drugs with more modest molecule size have broadened surface areas which lead to expand dissolution velocity. Higher the dissolution rate along with the subsequent higher focus angle between gastrointestinal lumen and foundational dissemination could additionally build oral bioavailability of drugs. A nanosuspension is a submicron colloidal scattering of drug particles which are balanced out by surfactants. A drug nanosuspension is characterized as finely scattered strong drug particles in a watery vehicle for oral, skin, parenteral or aspiratory administration. The molecule size circulation of the strong particles in nanosuspensions is normally short of what one micron with a normal molecule size going somewhere in the range of 200 and 600 nm. In nanosuspension innovation, the drug is kept up in the necessary glasslike state with decreased molecule size, prompting an expanded dissolution rate and accordingly improved bioavailability.^4,5,6

Norms for selection of drug for nanosuspension:

Nanosuspension can be ready for the API that is having both of the accompanying qualities:

a. Water insoluble yet which are dissolvable in oil (high logP) or API are insoluble in both water and oils.

b. Drugs with diminished inclination of the crystal to disintegrate, paying little mind to the dissolvable.

c. API with enormous portion.^7,8

Advantages of Nanosuspension:

a. Decreased tissue aggravation on account of subcutaneous/intramuscular administration.

b. Enhanced dissolution rate and immersion dissolvability of the drug.

c. Long-term actual solidness.

d. Higher drug stacking can be achieved.

e. Higher bioavailability for ocular administration and drug delivery by inhalation.

f. Nanosuspension can be utilized in creams, gel, pellets, tablets.⁹

Disadvantages of Nanosuspension:

a. Physical steadiness, sedimentation and compaction can cause issues.

b. Improper dose.

c. Uniform and exact dose can't be cultivated.

d. It is massive adequate consideration to be taken during handling and transport.

e. Uniform and explicit doses can't be accomplished except if suspended.¹⁰

A. Formulation Considerations of Nanosuspension:

· Stabilizer:

A stabilizer is utilized to wet the drug particles efficiently and to forestall the developing and agglomeration of nanosuspension by giving a stearic or ionic hindrance to yield a truly steady formulation. Drug particles scattered inside a fluid consistent medium are settled by steric, electrostatic components, or by a mix of both through polymers or potentially Surfactants. Steric adjustment is typically granted by nonionic polymers and nonionic surfactants, e.g., cellulose subordinates, poloxamers (additionally considered as polymeric surfactants), polysorbates, and povidones, keeping particles from getting into the scope of alluring Vander Waals powers. Electrostatic adjustment is typically granted by ionic surfactants, e.g., sodium dodecyl sulfate (SDS), dioctyl sulfosuccinate sodium salt (DOSS) and benzethonium chloride (BKC) giving shared shock of comparable charged particles.¹¹

· Organic Solvent:

Harmfulness potential and the simplicity of their evacuation after formulation are the two indispensable viewpoints that choose the reasonableness of natural solvents in the pharmaceutical territory during the formulation of nanosuspension by utilizing emulsion or microemulsion as layouts. Ethanol and isopropanol are water miscible solvent, though ethyl acetic acid derivation, ethyl formate, butyl lactate, triacetin, propylene carbonate and benzyl alcohol are partially water-miscible, less risky and pharmaceutically satisfactory.¹²

· Surfactants:

To enlighten the dispersion, it is consolidated into a formulation surfactant which plays out its activity as wetting or deflocculating decreasing the pressure of the interfaces. Ordinarily utilized surfactants are polysorbate (Tween/Span arrangement), povidone, poloxamers and lecithin.¹³

· Co-Surfactants:

This portrays other co-surfactants for explicit stabilizers that can be utilized securely in microemulsion formulation; co-surfactants like salts (dipotassium glycyrrhizinate) can be utilized securely with stabilizers like glycerol, ethanol, etc.¹⁴

· Methods of preparation of Nanosuspension:

In fact, formulation of nanosuspensions is easier option than liposomes and other regular colloidal drug transporters however answered to be cheaper. It is especially for ineffectively soluble drugs and to yield a genuinely steadier product. For assembling nanosuspensions, there are two speak techniques, "Top-down process technology" and "Bottom-up process technology". Top-down methodologies start from a bigger component of material, cutting or processing this mass material, to get more modest units of the ideal shape. Bottom-up methodologies organize more modest subunits or segments (e.g., particles or atoms) into bigger and practically more extravagant, complex designs. Models for drugs readied as nanosuspensions by these techniques incorporate griseofulvin, nabilone, atorvastatin. The following techniques are utilized to prepare nanosuspension^15,16,17

1. Bottom-up Technology:

This methodology begins from the bottom for example start from molecular level and in conclusion goes to a molecular relationship for the formulation of little solid particles. It is by and large used for the assembling of nanosuspensions both in mass arrangements or in single drops. In this procedure, the drug is altogether broken down in a dissolvable. At that point the dissolvable arrangement is added to a non-dissolvable, causing precipitation of the drug.¹⁸

· Precipitation method/Solvent- Antisolvent Method:

Precipitation method has been utilized for long a long time for the formulation of submicron particles. It is predominantly utilized for the ineffectively soluble drugs. First drug is disintegrated in an appropriate solvent. This arrangement is then blended in with a miscible anti-solvent framework within the sight of surfactants. Fast addition of drug arrangement in to the counter dissolvable prompts the unexpected supersaturation of drug in the blended arrangement structures ultrafine drug solids. Precipitation strategy includes two stages:

Nuclei arrangement and Crystal development. While setting up a steady suspension with the base molecule size, a high nucleation rate and yet low development rate is vital. The two rates are relying upon temperature. In this procedure the drug should be dissolvable in any event one solvent which is miscible with non-solvent.^19,20

2. Top down Technology:

Top down strategies incorporate procedures like grinding (media milling), high pressure homogenization, neosporosis, consolidated precipitation and homogenization (nano edge), nano jet innovation, emulsification-dissolvable dissipation strategies, hydrosol process, supercritical liquid strategy, precipitation method, dry-co-grinding.²¹

· Media milling:

Nanosuspensions are created by utilizing high-shear media mills or pearl mills. The factory comprises of a processing chamber, processing shaft and are course chamber. A watery suspension of the drug is then taken care of into the plant containing little grinding balls/pearls. As these balls pivot at a high shear rate under controlled temperature, they fly through the grinding container inside and sway against the sample on the contrary grinding container divider. The joined powers of grinding and impact produce a serious level of molecule size decrease. The milling media or balls are made of ceramic sintered aluminum oxide or zirconium oxide or exceptionally cross-connected polystyrene gum with high scraped area obstruction. Planetary ball mills (PM100 and PM200; Retsch GmbH and Co., KG, Haan, Germany) is one illustration of hardware that can be utilized to accomplish a pound size underneath 0.1μm. The significant disadvantages of this innovation incorporate the disintegration of balls/pearls that can leave buildups as foreign substances in the end result, debasement of the thermolabile drugs because of the warmth created during the interaction and presence of generally high extents of particles ≥5 μm.^22,23,24

· Homogenization:

a. High Pressure Homogenization (Dissocubes):

In this strategy suspension is constrained by a pressure unclogger siphon through a restricted valve under high pressure. At the point when the suspension is permitted to go through the hole the static pressure will be decreased underneath the bubbling pressure of water which brings about the bubbling of water and arrangement of gas bubbles. At the point when it leaves the opening pressure will be ordinary and air pockets will collapse. So, encompassing particles will hurry into the surface which causes the size decrease. This guideline is utilized in apvgaulin micron lab 40 homogenizer.²⁵

Figure 2: High Pressure Homogenization (Dissocubes)

b. Homogenization in Non- aqueous media (Nanopure):

It includes homogenization in water combinations or water free media and is ready for the thermolabile compound. Nano pure is additionally called as profound freezing since homogenization of drug suspension is done in non-fluid media at 0℃.²⁶

c. Combined Precipitation and Homogenization (Nano edge):

The fundamental standards of Nanoedge are the equivalent at that of precipitation and homogenization. A mix of these methods brings about more modest molecule size and better stability in a more limited time. The significant disadvantage of the precipitation method, like crystal development and long-term stability, can be settled utilizing the Nanoedge technology. In this method, the accelerated suspension is additionally homogenized, prompting a decrease in molecule size and staying away from crystal development. Precipitation is acted in water utilizing water-miscible solvents like methanol, ethanol and isopropanol. It is alluring to eliminate those solvents totally, despite the fact that they can be endured to a limited degree in the detailing.^27,28,29

d. Nano jet Technology:

This strategy, called inverse stream or nanotechnology, utilizes a chamber where a surge of suspension is isolated into at least two sections, which colloid with one another at high pressure. The high shear power delivered during the cycle brings about molecule size decrease. Hardware utilizing this guideline incorporates the M110L and M110 Smicrofluidizers (Microfluidics). Dearn arranged nanosuspensions of atovaquone utilizing the microfluidization cycle. The significant burden of this procedure is the high number of goes through the microfluidizer and that the item acquired contains a generally bigger part of microparticles.³⁰

· Emulsification-solvent evaporation Technique:

This strategy includes setting up a solution of drug followed by its emulsification in another fluid that is a non-solvent for the drug. Evaporation of the solvent prompt’s precipitation of the drug. Crystal development and molecule conglomeration can be constrained by making high shear powers utilizing a fast stirrer.^31,32

· Supercritical fluid (SCF) Method:

Supercritical fluid innovation can be utilized to create nanoparticles from drug solutions. The different strategies endeavored are quick extension of supercritical solution process (RESS), supercritical antisolvent interaction and precipitation with packed anti-solvent cycle (PCA). The RESS includes extension of the drug solution in supercritical fluid through a nozzle, which prompts loss of solvent force of the supercritical fluid bringing about precipitation of the drug as fine particles. Young et al. Arranged cyclosporine nanoparticles in the size range of 400-700nm utilizing this interaction. In the PCA technique, the drug solution is atomized into a chamber containing compacted CO2. As the solvent is taken out, the solution gets supersaturated and consequently encourages as fine crystals. The supercritical anti-solvent processuses a supercritical fluid wherein a drug is ineffectively dissolvable and a solvent for the drug that is additionally miscible with the supercritical fluid. The drug solution is infused into the supercritical fluid and the solvent gets extricated by the supercritical fluid and the drug solution gets supersaturated. The drug is then encouraged as fine crystals. Nanoparticles of griseofulvin, a drug with helpless dissolvability, were set up utilizing this strategy.^33,34

· Other Methods:

a. Micro emulsions as templates.

b. Hydrosol method:

This is like the emulsification-solvent evaporation strategy. The lone contrast between the two strategies is that the drug solvent is miscible with the drug anti-solvent. Higher shear power forestalls crystal development and Ostwald maturing and guarantees that the hastens stay more modest in size.^35,36,37

· Characterization Methods:

Nanosuspensions are portrayed for appearance, colour, odour, assay, related contaminations, molecule size, zeta potential, crystalline status, dissolution considers and in-vivo studies. Among this, the main portrayal procedures were examined.

1. Mean Particle Size:

The mean particle size and the range of particle size distribution (polydispersity index, PI) are two significant trademark boundaries since they influence the immersion solubility, dissolution rate, actual stability, even in-vivo conduct of nanosuspensions. It has been indicated by Muller and Peters (1998) that immersion solubility and dissolution velocity show extensive variety with the changing particle size of the drug.Particle size distribution determines the physiochemical conduct of the definition, like immersion solubility, dissolution velocity, actual stability, and so on The particle size distribution can be determined by photon correlation spectroscopy (PCS), laser diffraction (LD) and coulter counter multisizer.PCS can even be utilized for determining the width of the particle size distribution (polydispersity index, PI). The PI is a significant boundary that oversees the actual stability of nanosuspensions and ought to be just about as low as workable for the long-term stability of nanosuspensions.³⁸

2. Particle Charge (Zeta Potential):

The principal job of particle size in nanosuspension is basic to maintaining nanosuspension stability. The electrical charge on a particle surface induces electrostatic repugnance between the nanoparticles and forestalls aggregation and precipitation of particles, demonstrating the twofold electrical coating around a charged particle. The twofold layer is made out of a harsh layer and a contrary dissemination layer. For a steady suspension balanced out exclusively by electrostatic repugnance, a minimum zeta potential of ±30mV is required while if there should be an occurrence of a combined electrostatic and steric stabilizer, a zeta potential of ±20mV would be adequate. Particles charge is normally determined by measuring electrophoretic endless supply of an electric field which is then changed over to zeta potential.³⁹

3. Crystallinity of Particle and its Morphology:

Since nanosuspension requires high-pressure homogenization, there is a move in the crystalline plan structure that can be changed into either amorphous or other polymorphic forms. Changes in the strong condition of the item particles and the size of the amorphous segment are determined by the X-ray diffraction examination and followed by a differential calorimetry scanning investigation.^40,41

4. Saturation Solubility:

Nanosuspensions have a significant favorable position over different strategies, that it can increase the dissolution velocity just as the immersion solubility. The immersion solubility of the drug in various physiological buffers just as at various temperatures ought to be surveyed using techniques portrayed in the literature. The investigation of the dissolution velocity of nanosuspensions mirrors the points of interest that can be accomplished over conventional formulations, particularly when designing the sustained delivery measurement structures dependent on nanoparticulate drugs. The evaluation of immersion solubility and dissolution velocity helps in determining the in vitro conduct of the formulation.^42,43

5. Stability:

Decrease in particle size brings about increased surface energy because of the more noteworthy number of shaky surface atoms and molecules. The assessment of the immersion solubility assists with investigating any adjustment in the in vivo execution (blood profiles, plasma pinnacles, and bioavailability) of the drug. The utilization of stabilizers is to maintain a strategic distance from the group making of particle and diminish the odds for Ostwald ripening. The combination of surfactants and polymers is advantageous for the drawn-out adjustment of nanosuspensions.⁴⁴

6. Total drug content:

Take the necessary aliquot (0.5ml) of nanosuspension and subject to dissipation. The obtained buildup is broken down in appropriate organic solvent and sifted using 0.45µm filter. The total drug content is assessed employing reasonable analytical method.⁴⁵

Total drug content = (Total volume of nanosuspension Amount of drug in aliquot) Volume of aliquot

· Applications of Nanosuspension⁴⁶:

Figure 3: Applications of Nanosuspension

CONCLUSION:

Nanosuspension tackled helpless bioavailability issue of hydrophobic drugs and drugs which are inadequately soluble in watery and organic solutions. Enormous scale production of nanosuspension can be utilized by media milling and high-pressure homogenization procedure. This innovation is gaining importance as the quantity of particles with solubility and bioavailability related issues are increasing day by day. Consequently, nanotechnology can assume a fundamental part in drug discovery projects to increase watery solubility just as bioavailability of inadequately soluble drugs.

ACKNOWLEDGEMENT:

We are grateful to the teacher’s and Principal of Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Tal. Kalwan for their helpful guidance.

REFERENCES:

1. Wagh KS, Patil SK, Akarte AK, Baviskar DT; Nanosuspension – a new approach of bioavailability enhancement, International Journal of Pharmaceutical Sciences Review and Research, 2011; 8: 60-62.

2. Lakshmi P, Kumar GA; Nanosuspension technology: a review; International Journal of Pharmacy and Pharmaceutical Sciences, 2010; 2: 35-40.

3. Sarika V. Kandbahale. A Review- Nanosuspension Technology in Drug Delivery System. Asian J. Pharm.Res. 2019; 9(2): 130-138. Doi: 10.5958/2231-5951.2019.00021.2

4. Soumya M, Gupta S, Jain R, Mazumder R; Solubility enhancement of poorly water-soluble drug by using nanosuspension technology, International Journal of Research and Development in Pharmacy and Life Sciences. 2013; 2: 642-649.

5. Kavitha VB, Neethu CS, Dineshkumar B, Krishnakumar K, John A; Nanosuspension Formulation; An Improved Drug Delivery System. Nanoscience and Nanotechnology: An International Journal, 2014; 2: 1-5.

6. Arunkumar N, Deecarman M, Rani C; Nanosuspension technology and its application in drug delivery. Asian Journal of Pharmaceutics. 2009; 3: 168-173. DOI: 10.4103/0973-8398.56293

7. Shid RL, Dhole SN, Kulkarni N, Shid SL; Nanosuspension: A Review. Int J. Pharm. Sci. Rev. Res., 2013; 22(1): 98-106.

8. Patel HM, Patel BB, Shah CN, Shah DP. Nanosuspension Technologies for Delivery of Poorly Soluble Drugs – A Review. Research Journal of Pharmacy and Technology. 2016; 9(5): 625-32.

9. Azimullah S, Sudhakar CK, Kumar P, Patil A, Usman MR, Usman MZ, Jain BV. Nanosuspension as a promising approach to enhance bioavailability of poorly soluble drugs: An update. Journal of Drug Delivery and Therapeutics. 2019; 9(2): 574-82. DOI: 10.22270/ jdtt.v9i2.2436

10. Li M, Azad M, Dave R, Bilgili E. Nanomilling of drugs for bioavailability enhancement: a holistic formulation- process perspective. Pharmaceutics. 2016; (2): 17. DOI: 10.3390/ pharmaceutics8020017.

11. Ghosh I, Michniak-Kohn B, Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin- A case study. AAPS Pharm Sci Tech; 2013; 14(3): 1108-17 https://doi.org/10.1208/s112249-013-9995-4.

12. Geetha G, Poojitha U, Khan AA. Various techniques for preparation of nanosuspension- A Review. International Journal of Pharma Research and Review. 2014; 3(9): 30-7. DOI: 10.12691/ nnr-4-2-4.

13. Babu VR, Aleem MA, Nikhat SR, Aslam S, Khan M. Nanosuspension Technology for Poorly Water-Soluble Drugs: An Overview. Research Journal of Pharmacy and Technology. 2011; 4(4): 515-20. https://www.indianjournals.com/ijor.aspx?target= ijor: rjptand volume=4andissue=4andarticle=006.

14. Purkayastha HD, Hossain SI. Nanosuspension: a modern technology used in drug delivery system. Int J Curr Pharm Res. 2019; 11(3): 1-3. DOI: 10.22159/ijcpr.2019v11i3.34098.

15. Yadav GV, Singh SR. Nanosuspension: A promising drug delivery system. Pharmacophore. 2012; 3(5): 217-43.

16. Tehrani AA, Omranpoor MM, Vatanara A, Seyedabadi M, Ramezani V. Formation of nanosuspensions in bottom-up approach: theories and optimization. DARU Journal of Pharmaceutical Sciences. 2019 19; 1(27): 451-473. DOI:10.1007/ s40199-018-00235-2.

17. Junyaprasert VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian journal of pharmaceutical sciences. 2015; 10(1): 13-23. DOI: 10.1016/ j.ajps.2014.08.005

18. Peters K, Leitzke S, Diedrichs JE, Borner K, Hahn H, Moller RH; Preparation of clofazimine nanosuspensions for intravenous use and evaluation of its therapeutic efficacy in murine mycobacterium avium infection. J Antimicrobe Chemother, 2000; 45: 77-83.

19. Singh MC, Sayyad AB, Sawant SD. Review on various techniques of solubility enhancement of poorly soluble drugs with special emphasis on solid dispersion. J Pharm Res. 2010; 3(10): 2494-501.

20. BP Patel. A review on techniques which are useful for solubility enhancement of poorly water-soluble drugs. Int J for Res Management Pharm 2012; 1: 56-70.

21. Siddeswara m. Pradeep Kumar M. Santosh Raja M. Yasmin S. Review on Nanosuspension, Asian J. Pharm. 2016.

22. S Varun, R Kapoor, K Preet. Taste masking and formulation of ofloxacin rapid disintegrating tablets and oral suspension. Indian J Pharm Edu Res 2009; 43: 150-5.

23. Chen Y, Liu J, Yang X, Xu H; Oleanolic acid nanosuspensions: formulation in-vitro characterization and enhanced hepatoprotective effect. J Pharm. Pharmacol., 2005;57:259-264.

24. Chandra A, Sharma U, Jain SK, Soni RK. Nanosuspension: An overview. Journal of Drug Delivery and Therapeutics. 2013 14; 3(6): 162-7. DOI: 10.22270/jddt.v3i6.677

25. Yadollahi R, Vasudev K, Simovic S. Nanosuspension technologies for delivery of poorly soluble drugs. Journal of Nanomaterials. 2015 1; 2015: 1-13. DOI: 10.1155/2015/216375

26. J Chingunpituk. Nanosuspension technology for drug delivery. Walailak Journal of Science and Technology (WJST). 2011; 4(2): 139-53. http://wjst.wu.ac.th/index.php/wjst/article/view/94

27. Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G. Preparation and Characterization of Eudragit retard nanosuspensions for the ocular delivery of Cloricromen. AASP pharmacitech; 7: E27

28. Rainbow BE. Nanosuspensions in drug delivery. Nature reviews Drug discovery. 2004; 3(9): 785-96. DOI: 10.1038/nrd1494

29. Vyas I, Daxini K, Patel I. Formulation and Characterization of Moxifloxacin Nanoparticles with Ion Exchange Resin. Journal of Drug Delivery and Therapeutics. 2020; 10(1): 51-61. DOI: 10.22270/jddt.v10i1-s.3853

30. D Prasanta. Nanotechnology for the delivery of poorly water-soluble drugs. Global J Pharma Res 2012; 1: 225-50.

31. Harsh Joshi, Priyanka Ahlawat. Solid Lipid Nanoparticles for nose to brain deliver: A review. Res. J. Pharma. Dosage Forms and Tech. 2021; 13(1): 57-61, doi: 10.5958/09754377.2021.00010.0

32. Jacob S, Nair AB, Shah I. Emerging role of nanosuspension in drug delivery systems. Biomaterials Research. 2020; 24(1): 1-16. DOI: 10.1186/s40824-020-0184-8

33. Bhalekar M, Upadhya P, Reddy S, Kshirsagar S, Madgulkar A, Formulation and evaluation of acyclovir nanosuspension for enhancement of bioavaibility. Asian J. Pharma 2014; 8: 110-8.

34. Sun I, Wang F, Sui Y, She Z, Zhai W, Wang C, Deng Y. Effect of particle size on solubility, dissolution rate, and oral bioavailability: Evaluation using coenzyme Q10 as naked nanocrystals. International journal of nanomedicine. 2012; 7(2): 5733-5744. DOI: 10.2147/IJN.S34365

35. Du J, Li X, Zhao H, Zhou Y, Wang L, Tian S, Wang Y. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. International journal of pharmaceutics. 2015; 495(2): 738-49. DOI: 10.1016/i.ijpharm.2015.09.021

36. Gray V, Cady S, Curran D, DeMuth I, Eradiri O, Hussain M, Kramer I, Shabushnig I, Stippler E. In Vitro Release Test Methods for Drug Formulations for Parenteral Applications. Dissolution Technologies. 2018; 25(4): 8-13.

37. Khan AD, Singh L. Various techniques of bioavailability enhancement: a review. Journal of Drug Delivery and Therapeutics. 2016; 6(3): 34-41. DOI: 1022270/jddt.v6i3.1228

38. Amrutkar N, Deecaraman M, Rani C, Nanosuspension Technology and Its Applications in Drug Delivery, AAPS sci Tech; 2009: 3(3) doi: http://dx.doi.org/10.22377/ajp.v3i3.261

39. Shivhare R, Pathak A, Shrivastava N, Singh C, Tiwari G, Goyal R. An update review on novel advanced ocular drug delivery system. World Journal of Pharmacy and Pharmaceutical Sciences. 2012; 1(2): 545-68. DOI: 10.2174/187221111795471436

40. Atul P, Pallavi J, Chaudhari P. Nanosuspension: A promising Nanocarrier Drug Deliver System. Research J. Pharma. Dosage forms and Tech. 2011; 3(5): 176-182

41. Liu D, Xu h. Tian B, Yuan K, Pan H, Ma S. Fabrication of carvedilol nanosuspension through the anti-solvent precipitation ultrasonication method for the improvement of dissolution rate and oral bioavaibility. AAPS pharma sci Tech 2012; 13: 295-304

42. Sharma P, Garg S. Pure drug and polymer-based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Advanced drug delivery reviews. 2010 2010;18; 62(4-5): 491-502. DOI: 10.1016/j.addr.2009.11.019

43. Chen A, Shi Y, Yan Z, Hao H, Zhang Y, Zhong J, Hou H. Dosage form developments of nanosuspension drug delivery system for oral administration route. Current pharmaceutical design. 2015; 21(29): 4355-65. DOI: 10.2174/1381612821666150901105026.

44. Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. Journal of Nanoparticle Research. 2008; 10(5): 845-62. DOI: 10.1007/s11051-008-9357-4

45. D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Advances in Pharmaceutics. 2014; 2014: 1-12. DOI: 10.1155/2014/30

46. Bhakay A, Rahman M, Dave RN, Bilgili E. Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: Formulation- Processing aspects and challenges. Pharmaceutics. 2018; 10(3): 86. DOI: 10.3390/pharmaceutics10030086

Received on 27.03.2021 Modified on 20.04.2021

Asian Journal of Pharmacy and Technology 2021; 11(3):252-258.

DOI: 10.52711/2231-5713.2021.00042